Nli Healthcare (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-06-2024
- Paid Up Capital ₹ 1.00 M
as on 17-06-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -0.85%
(FY 2022)
- Profit 12.20%
(FY 2022)
- Ebitda 7.57%
(FY 2022)
- Net Worth 43.16%
(FY 2022)
- Total Assets 94.20%
(FY 2022)
About Nli Healthcare (India)
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nirmal Mulye, Jayant Ranade, and Shraddha Dhamankar serve as directors at the Company.
- CIN/LLPIN
U24304MH2019FTC321281
- Company No.
321281
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
15 Feb 2019
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nli Healthcare (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirmal Mulye  | Director | 15-Feb-2019 | Current |
Jayant Ranade  | Director | 15-Feb-2019 | Current |
| Shraddha Dhamankar | Director | 15-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Nli Healthcare (India).
Nli Healthcare (India) Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.85% decrease. The company also saw a substantial improvement in profitability, with a 12.2% increase in profit. The company's net worth Soared by an impressive increase of 43.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nli Healthcare (India)?
In 2022, Nli Healthcare (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Enem Nostrum Remedies Private LimitedActive 23 years 11 monthsNirmal Mulye and Shraddha Dhamankar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nli Healthcare (India)?
Nli Healthcare (India) has a workforce of 6 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nli Healthcare (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nli Healthcare (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
